$0.37
1.22% yesterday
Nasdaq, Apr 11, 10:00 pm CET
ISIN
US2826442020
Symbol
EKSO

Ekso Bionics Holdings, Inc. Target price 2025 - Analyst rating & recommendation

Ekso Bionics Holdings, Inc. Classifications & Recommendation:

Buy
100%

Ekso Bionics Holdings, Inc. Price Target

Target Price $5.00
Price $0.37
Potential
Number of Estimates 2
2 Analysts have issued a price target Ekso Bionics Holdings, Inc. 2026 . The average Ekso Bionics Holdings, Inc. target price is $5.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 2 analysts: 2 Analysts recommend Ekso Bionics Holdings, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ekso Bionics Holdings, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Ekso Bionics Holdings, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 17.93 22.00
1.91% 22.68%
Net Margin -69.34% -39.36%
48.10% 43.23%

2 Analysts have issued a sales forecast Ekso Bionics Holdings, Inc. 2025 . The average Ekso Bionics Holdings, Inc. sales estimate is

$22.0m
Unlock
. This is
22.68% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$24.0m 33.81%
Unlock
, the lowest is
$20.0m 11.54%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $17.9m 1.91%
2025
$22.0m 22.68%
Unlock
2026
$30.1m 37.02%
Unlock
2027
$39.4m 30.73%
Unlock
2028
$49.9m 26.76%
Unlock
2029
$62.8m 25.65%
Unlock

1 Analyst has issued a net profit forecast Ekso Bionics Holdings, Inc. 2025 . The average Ekso Bionics Holdings, Inc. net profit estimate is

$-8.7m
Unlock
. This is
31.56% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-8.7m 31.56%
Unlock
, the lowest is
$-8.7m 31.56%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-12.4m 49.09%
2025
$-8.7m 30.34%
Unlock
2026
$-4.4m 48.73%
Unlock

Net Margin

2024 -69.34% 48.10%
2025
-39.36% 43.23%
Unlock
2026
-14.73% 62.58%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share $ -0.56 -0.39
49.09% 30.36%
P/E negative
EV/Sales 0.45

1 Analysts have issued a Ekso Bionics Holdings, Inc. forecast for earnings per share. The average Ekso Bionics Holdings, Inc. EPS is

$-0.39
Unlock
. This is
31.58% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.39 31.58%
Unlock
, the lowest is
$-0.39 31.58%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.56 49.09%
2025
$-0.39 30.36%
Unlock
2026
$-0.20 48.72%
Unlock

P/E ratio

Current -0.64 50.39%
2025
-0.94 46.88%
Unlock
2026
-1.83 94.68%
Unlock

Based on analysts' sales estimates for 2025, the Ekso Bionics Holdings, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.55 58.02%
2025
0.45 19.07%
Unlock
2026
0.32 27.03%
Unlock
2027
0.25 23.49%
Unlock
2028
0.20 21.13%
Unlock
2029
0.16 20.41%
Unlock

P/S ratio

Current 0.57 58.69%
2025
0.47 18.49%
Unlock
2026
0.34 27.03%
Unlock
2027
0.26 23.50%
Unlock
2028
0.21 21.12%
Unlock
2029
0.16 20.42%
Unlock

Current Ekso Bionics Holdings, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
Locked
Locked Mar 04 2025
Lake Street
Locked
Locked
Locked Mar 04 2025
HC Wainwright & Co.
Locked
Locked
Locked Jan 14 2025
HC Wainwright & Co.
Locked
Locked
Locked Oct 29 2024
Lake Street
Locked
Locked
Locked Oct 29 2024
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 04 2025
Locked
Lake Street:
Locked
Locked
Mar 04 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jan 14 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Oct 29 2024
Locked
Lake Street:
Locked
Locked
Oct 29 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today